Renae Mayer, MD
Internal Medicine · Tulsa, OKNPI 1093752503
Payments from drug & device makers
Across 272 payments — averaging $2815.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novavax Inc$360K
- Merck$298K
- Alnylam Pharmaceuticals Inc.$32K
- Amgen$19K
- AbbVie$19K
- Biohaven Pharmaceuticals, Inc.$9K
- plus $28K from 15 others
Across 1 payment — averaging $2900.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novavax Inc | 29 | $359,923 |
| Merck | 8 | $297,762 |
| Alnylam Pharmaceuticals Inc. | 119 | $32,287 |
| Amgen | 2 | $19,400 |
| AbbVie(2 entities) | 6 | $18,842 |
| Biohaven Pharmaceuticals, Inc. | 1 | $9,250 |
| UCB SA | 5 | $8,239 |
| Sanofi Pasteur Inc. | 2 | $7,800 |
| Pfizer | 3 | $6,710 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $2,620 |
| Daiichi Sankyo Inc. | 40 | $1,018 |
| UCB GmbH | 13 | $914 |
| Johnson & Johnson | 20 | $537 |
| Novartis | 12 | $320 |
| Esperion Therapeutics, Inc. | 1 | $125 |
| Novo Nordisk | 2 | $34 |
| Philips North America LLC | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$765,877 in reported general payments places this provider in the 95th percentile of 840 internal medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Tulsa
- Al-Ola AbdallahTulsa$10.1M
- Melita TateTulsa$9.1M
- Mousumi SomTulsa$391K
- Jesse RichardsTulsa$279K
- Madhuri LadTulsa$195K
- Lam leTulsa$191K
- Stacy ChronisterTulsa$163K
- Katherine CookTulsa$41K
- Layth Al AttarTulsa$35K
- Gerard McNultyTulsa$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.